| Article | Date | Source |
|---|
| Acton Pharmaceuticals, Inc. Announces License Agreement with for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
| October 25, 2011 | BioSpace |
| Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol Company's pipeline includes two NDA-stage respiratory compounds that will compete in the multi-billion dollar allergy and | October 25, 2011 | Pharmaceutical - Moreover |
| Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA™ (triamcinolone acetonide) Nasal Aerosol | October 25, 2011 | Pharma News - Business Wire |
| Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology | October 11, 2011 | Pharmaceutical - Moreover |
| Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology
| October 11, 2011 | BioSpace - Breaking News |
| Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN® (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology | October 11, 2011 | Pharma News - Business Wire |
| Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R) (flunisolide HFA, 80 mcg) Inhalation Aerosol | November 03, 2010 | BioSpace - Breaking News |
| Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN® (flunisolide HFA, 80 mcg) Inhalation Aerosol | November 03, 2010 | Pharma News - Business Wire |
| Acton Pharmaceuticals, Inc. Forms Scientific Advisory Board | May 24, 2010 | Pharma News - Business Wire |
| Acton Pharmaceuticals, Inc.: Series A $15M | February 18, 2010 | OnBioVC |
| Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital | January 06, 2010 | BioSpace |
| Acton Pharma closes on $15M in financing | January 06, 2010 | Health News - BizJournals.com |
| Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug | January 06, 2010 | Xconomy Life Sciences |
| <b>Acton Pharmaceuticals, Inc.</b> Announces Completion of $15 Million Series A Financing with <b>Sequoia Capital</b> | January 06, 2010 | BioSpace |
| Acton Pharma closes tranche in VC round | December 15, 2009 | Health News - BizJournals.com |
